Kompella Uday 4
4 · Ocugen, Inc. · Filed Jun 1, 2021
Insider Transaction Report
Form 4
Ocugen, Inc.OCGN
Kompella Uday
Director
Transactions
- Sale
Common Stock
2021-05-28$8.82/sh−7,191$63,417→ 550,674 total - Exercise/Conversion
Common Stock
2021-05-28$1.88/sh+7,191$13,519→ 557,865 total - Exercise/Conversion
Option (right to buy)
2021-05-28−7,191→ 0 totalExercise: $1.88Exp: 2025-08-26→ Common Stock (7,191 underlying)
Holdings
- 479,416(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.81 to $8.86. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The option, initially representing a right to purchase a total of 7,191 shares, vested and became exercisable on September 27, 2019.